Mucpharm
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L3 Pitney Building Short St, Kogarah, Ne...Phone Number
+61 291132070Website
www.mucpharm.comRevenue
<$5 MillionIndustry
About Mucpharm
Mucpharm Org Chart
Is Mucpharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Mucpharm had a recent Job posting/layoffs
Mucpharm, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mucpharm
Earning: See what the market has to say on Mucpharm recently announced quarterly report
Funding: Get notified immidiatlly once Mucpharm has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mucpharm has recently received funding, and reach out quickly before it becomes old news!
Check out if Mucpharm is spiking on competitors!
Product Launch: Get notified when Mucpharm launches new products
Recommended Actions
Find VP level buyers at Mucpharm
Find 3 more new buyers
Compare Similar Companies to Mucpharm
Compare insights from companies similar to Mucpharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mucpharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mucpharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mucpharm.
Mucpharm Tech Stack
A closer look at the technologies used by Mucpharm
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mucpharm
Mucpharm is a specialized company dedicated to developing treatments for mucin-containing and secreting conditions, particularly focusing on advanced cancers such as pseudomyxoma peritonei. Their lead compound, BromAc, is being investigated in clinical trials for its efficacy in oncology and respiratory diseases, aiming to improve treatment outcome... Read More